Citation: G. Gomez et al., Immunosuppressive effects of extracellular adenosine on immune cells: Implications for the pathogenesis of ADA SCID and immunomodulation, DRUG DEV R, 53(2-3), 2001, pp. 218-224
Authors:
Caldwell, CC
Kojima, H
Lukashev, D
Armstrong, J
Farber, M
Apasov, SG
Sitkovsky, MV
Citation: Cc. Caldwell et al., Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions, J IMMUNOL, 167(11), 2001, pp. 6140-6149
Citation: H. Kojima et al., Comparison of Fas- versus perforin-mediated pathways of cytotoxicity in TCR- and Thy-1-activated murine T cells, INT IMMUNOL, 12(3), 2000, pp. 365-374
Authors:
Chen, LP
Hardwick, JP
McPhie, P
Sitkovsky, MV
Jacobson, KA
Citation: Lp. Chen et al., Purification and recognition of recombinant mouse P2X(1) receptors expressed in a baculovirus system, DRUG DEV R, 51(1), 2000, pp. 7-19
Citation: Fa. Redegeld et al., Ecto-protein kinases: ectodomain phosphorylation as a novel target for pharmacological manipulation?, TRENDS PHAR, 20(11), 1999, pp. 453-459
Citation: Sg. Apasov et Mv. Sitkovsky, The extracellular versus intracellular mechanisms of inhibition of TCR-triggered activation in thymocytes by adenosine under conditions of inhibited adenosine deaminase, INT IMMUNOL, 11(2), 1999, pp. 179-189
Authors:
Koshiba, M
Rosin, DL
Hayashi, N
Linden, J
Sitkovsky, MV
Citation: M. Koshiba et al., Patterns of A(2A) extracellular adenosine receptor expression in differentfunctional subsets of human peripheral T cells. Flow cytometry studies with anti-A(2A) receptor monoclonal antibodies, MOLEC PHARM, 55(3), 1999, pp. 614-624